A1M Pharma AB has changed its name to Guard Therapeutics International AB

Visit guardtherapeutics.com

The American Society of Nephrology (ASN) has selected preclinical studies of the drug candidate ROSgard™ for presentation at the organization's International Congress Kidney Week in Washington

05 Nov 2019 /

The American Society of Nephrology (ASN) has selected preclinical studies of the drug candidate ROSgard™ for presentation at the organization's International Congress Kidney Week in Washington

Link to ASN Kidney week 5-10 november